TirzepatiGen (Tirzepatide) – 10mg

د.إ 65

  • Advanced dual-agonist peptide (10mg)
  • Powerful appetite control
  • Metabolic efficiency
  • Fat-loss potential.

 

Free 1–3 Day Canada Post Express shipping on all orders over $125

  • Secured & Tracked
  • Order yours before 12.00pm for same day dispatch
Guaranteed Safe Checkout

Payment methods

Important: No product should be used without the explicit direction of a licensed physician.
Not All Peptides Are Made The Same. Suppliers may take shortcuts with dilution, solvents, or handling. BNSUSA follows documented lab processes and provides research-grade materials with clear batch documentation for every product.
TirzepatiGen (Tirzepatide) - 10mg
TirzepatiGen (Tirzepatide) – 10mg
د.إ 65

[wpforms id=”1190″ title=”true” description=”Request a call back”]

No lab results found for this product yet.


TirzepatiGen (Tirzepatide) is a dual incretin receptor agonist peptide frequently chosen by research teams exploring appetite regulation signaling, weight management pathways, and metabolic coordination in controlled models.


Overview

Tirzepatide is widely studied in research focused on appetite signaling networks, metabolic balance frameworks, and energy regulation pathways. In non-clinical models, research teams use this peptide to examine how combined incretin related communication may influence feeding behavior markers, lipid metabolism readouts, and glucose signaling indicators. This makes it a flexible option for projects centered on body composition research themes and metabolic efficiency analysis.


Mechanism and Research Focus

Tirzepatide targets both GLP-1 and GIP receptor pathways, key systems in research related to hunger communication, nutrient partitioning signals, and insulin related regulatory networks. Studies in structured and preclinical models have shown that coordinated activation of these pathways can influence satiety indicators, caloric intake markers, and metabolic readouts under standardized conditions. This allows research teams to track shifts in important markers linked to metabolic health research, appetite pathway analysis, and energy balance investigations.


Key Research Observations

Research has shown Tirzepatide may help support the following in non-clinical models:

Enhanced appetite control: Reduced feeding drive and smaller intake patterns recorded in controlled laboratory frameworks.

Satiety signaling support: Prolonged fullness related markers observed in structured preclinical systems.

Metabolic balance indicators: Favourable shifts in glucose and lipid readouts documented in standardized model analyses.

Weight management pathways: Measurable body composition marker changes recorded in non-clinical pathway research.


Benefits Seen in Various Research Settings

  • Appetite regulation pathways explored through controlled feeding behavior models.
  • Metabolic coordination signals tracked in structured glucose and lipid studies.
  • Energy balance markers analyzed in standardized caloric intake experiments.
  • Body composition signaling investigated in preclinical metabolic frameworks.
  • Dual incretin communication mechanisms examined in laboratory receptor interaction research.

Form and Handling

  • 98% research grade purity
  • Lyophilized powder
  • Store at -20°C and protect from light

Research Use Only

For laboratory research use only. Not for human or animal consumption, medical use, or any form of therapy.